Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0J9VA
|
||||
| Former ID |
DNC006418
|
||||
| Drug Name |
H-[Trp-Arg-Nva-Arg-Tyr]2-NH2
|
||||
| Indication | Discovery agent | Investigative | [528136] | ||
| Formula |
C74H107N25O12
|
||||
| Canonical SMILES |
CCCC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC<br />(CC2=CNC3=CC=CC=C32)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC)C(=O<br />)NC(CCCN=C(N)N)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)N)NC(=O)C(C<br />CCN=C(N)N)NC(=O)C(CC5=CNC6=CC=CC=C65)N
|
||||
| InChI |
1S/C74H107N25O12/c1-3-13-52(92-65(106)54(19-9-31-85-71(77)78)91-62(103)49(75)37-43-39-89-50-17-7-5-15-47(43)50)64(105)95-57(22-12-34-88-74(83)84)68(109)98-59(36-42-25-29-46(101)30-26-42)69(110)99-60(38-44-40-90-51-18-8-6-16-48(44)51)70(111)96-55(20-10-32-86-72(79)80)66(107)93-53(14-4-2)63(104)94-56(21-11-33-87-73(81)82)67(108)97-58(61(76)102)35-41-23-27-45(100)28-24-41/h5-8,15-18,23-30,39-40,49,52-60,89-90,100-101H,3-4,9-14,19-22,31-38,75H2,1-2H3,(H2,76,102)(H,91,103)(H,92,106)(H,93,107)(H,94,104)(H,95,105)(H,96,111)(H,97,108)(H,98,109)(H,99,110)(H4,77,78,85)(H4,79,80,86)(H4,81,82,87)(H4,83,84,88)/t49-,52-,53-,54-,55-,56-,57-,58-,59-,60-/m0/s1
|
||||
| InChIKey |
QTWWWOBSQULXHE-MTVPJWGZSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Neuropeptide Y receptor type 4 | Target Info | Inhibitor | [528136] | |
| Neuropeptide Y receptor type 2 | Target Info | Inhibitor | [528136] | ||
| Neuropeptide Y receptor type 1 | Target Info | Inhibitor | [528136] | ||
| NetPath Pathway | FSH Signaling Pathway | ||||
| References | |||||